MIR212

Across TCGA pan-cancer cohorts, MIR212 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR212 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MIR212 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR212 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

UVM, LUSC, and UCEC are the cancer types where MIR212 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.136	0.858	<.001	90	view →
LUSC	OS	Tertile	III,IV	0.086	0.684	<.001	36	view →
UCEC	DFS	Tertile	III,IV	0.051	0.572	.018	36	view →
KIRC	DFS	Tertile	IV	0.221	0.509	.023	30	view →
STAD	OS	Median	All	0.749	0.617	.020	29	view →
BLCA	DFS	Tertile	III,IV	0.131	0.493	.008	18	view →
COAD	DFS	Tertile	II,III,IV	0.133	0.545	.047	9	view →
SARC	OS	Tertile	All	0.140	0.516	.037	9	view →
HNSC	OS	Tertile	All	0.133	0.410	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR212–UVM (OS)

Open the UVM breakdown →